{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-25-000101","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2025-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.488063+00:00","generated_at":"2026-05-17T12:25:14.055147+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Salarius Pharmaceuticals effects 1-for-15 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective 5:00 p.m. ET on August 15, 2025; trading on split-adjusted basis from August 18, 2025.","Shares outstanding reduced from ~7.6M to ~509,000; no fractional shares, cash in lieu paid.","New CUSIP number 79400X503; authorized shares and par value unchanged.","Split approved by stockholders at July 8, 2025 special meeting; ratio set by Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-25-000101","json":"https://secwatch.observer/filing/0001615219-25-000101.json","markdown":"https://secwatch.observer/filing/0001615219-25-000101.md","text":"https://secwatch.observer/filing/0001615219-25-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000101/0001615219-25-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000101/flks-20250815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:25:14.055147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"52f364f674137268c11ecd812712200b65cafdbc","claim":"Decoy Therapeutics Inc.: Filed a Certificate of Amendment to effect a 1-for-15 reverse stock split of common stock (effective 2025-08-15).","evidence_excerpt":"On August 15, 2025, Salarius Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s amended and restated certificate of incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware , to effect a 1-for-15 reverse stock split (the “reverse split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “ Common Stock ”), effective at 5:00 p.m. Eastern Time on that date (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521925000101/0001615219-25-000101-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-08-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}